|
CREBL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.042900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.789600E-02 |
| Normal-vs-Stage2 |
2.957400E-01 |
| Normal-vs-Stage3 |
1.002850E-04 |
| Normal-vs-Stage4 |
9.24339999985868E-07 |
| Stage1-vs-Stage2 |
9.310200E-01 |
| Stage1-vs-Stage3 |
1.460130E-02 |
| Stage1-vs-Stage4 |
6.152500E-04 |
| Stage2-vs-Stage3 |
2.283400E-01 |
| Stage2-vs-Stage4 |
8.201500E-02 |
| Stage3-vs-Stage4 |
4.145000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.832100E-04 |
| Normal-vs-AfricanAmerican |
4.63829999997056E-06 |
| Normal-vs-Asian |
2.268000E-01 |
| Caucasian-vs-AfricanAmerican |
1.237870E-02 |
| Caucasian-vs-Asian |
7.096400E-01 |
| AfricanAmerican-vs-Asian |
5.989400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.360650E-04 |
| Normal-vs-Female |
4.498800E-03 |
| Male-vs-Female |
5.484400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.798400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.700900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.555900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.773800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.018800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.908600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.761800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.431000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.772200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.224200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.848400E-01 |
| Normal-vs-Grade 2 |
2.321400E-01 |
| Normal-vs-Grade 3 |
6.05009999999906E-05 |
| Normal-vs-Grade 4 |
1.2380000358192E-09 |
| Grade 1-vs-Grade 2 |
8.875000E-01 |
| Grade 1-vs-Grade 3 |
2.433600E-01 |
| Grade 1-vs-Grade 4 |
6.896600E-03 |
| Grade 2-vs-Grade 3 |
9.161500E-03 |
| Grade 2-vs-Grade 4 |
2.33510000002823E-07 |
| Grade 3-vs-Grade 4 |
5.645500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.766200E-01 |
| Normal-vs-ccB subtype |
2.90120000023819E-07 |
| ccA subtype-vs-ccB subtype |
3.43289999760188E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.232280E-02 |
| Normal-vs-N1 |
4.121700E-02 |
| N0-vs-N1 |
2.233200E-01 |
|
|
